Tel Aviv Sourasky Medical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tel Aviv Sourasky Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9317
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tel Aviv Sourasky Medical Center (Sourasky Medical) is an academic medical center that provides patient-centered care, research and education services. The center offers services in the areas of cardiology, dermatology, gastroenterology, general surgery, genetics, emergency medicine, rheumatology, neurology, oncology, and others. It provides services such as ophthalmology, endocrinology, infectious diseases, hematology, and others. Sourasky Medical also provides language translation; admission room, inpatient units, and maternity care, death and burial services, accessibility for people with disabilities, and others. The center offers service such as food and beverage, bewell program, medical records, private nursing and ambulance service, religious services, equipment rental and other support services. Sourasky Medical is headquartered in Tel Aviv, Israel.

Tel Aviv Sourasky Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tel Aviv Sourasky Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pluristem Enters into Agreement with Tel Aviv Sourasky 11
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 12
Kite Pharma Extends Research Agreement with Tel Aviv Medical Center to Develop Novel Chimeric Antigen Receptor (CAR) 13
Kite Pharma Enters into Research Agreement with Tel Aviv Medical Center 14
Tel Aviv Sourasky Medical Center – Key Competitors 15
Tel Aviv Sourasky Medical Center – Key Employees 16
Tel Aviv Sourasky Medical Center – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tel Aviv Sourasky Medical Center, Deals By Therapy Area, 2012 to YTD 2018 8
Tel Aviv Sourasky Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pluristem Enters into Agreement with Tel Aviv Sourasky 11
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 12
Kite Pharma Extends Research Agreement with Tel Aviv Medical Center to Develop Novel Chimeric Antigen Receptor (CAR) 13
Kite Pharma Enters into Research Agreement with Tel Aviv Medical Center 14
Tel Aviv Sourasky Medical Center, Key Competitors 15
Tel Aviv Sourasky Medical Center, Key Employees 16
Tel Aviv Sourasky Medical Center, Subsidiaries 17

List of Figures
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tel Aviv Sourasky Medical Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tel Aviv Sourasky Medical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abionic SA-医療機器分野:企業M&A・提携分析
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company offers products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone & iPad, and accessories. Its abioSCOPE in vitro tests are design …
  • Landeskreditbank Baden-Wuerttemberg-Foerderbank:企業の戦略・SWOT・財務分析
    Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report Summary Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • H.I.S. Co Ltd:企業の戦略・SWOT・財務分析
    H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Medical Transcription Billing Corp (MTBC)-医療機器分野:企業M&A・提携分析
    Summary Medical Transcription Billing Corp (Medical Transcription) is a healthcare IT company that offers web-based solutions and related business services. The company offers electronic health records, practice management software, and patient engagement software. Its products comprise ChartsPro, P …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • Hell Pizza:企業の戦略・SWOT・財務分析
    Hell Pizza - Strategy, SWOT and Corporate Finance Report Summary Hell Pizza - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Corvel Corporation:企業の戦略・SWOT・財務分析
    Corvel Corporation - Strategy, SWOT and Corporate Finance Report Summary Corvel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Academic Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as treatment of patients, medical research and medical education. It provides medical treatments and services for various …
  • Saudi Arabian Oil Co (2222):企業の財務・戦略的SWOT分析
    Saudi Arabian Oil Co (2222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Chiesi Farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, …
  • Verizon Communications Inc.:企業の戦略・SWOT・財務情報
    Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report Summary Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Energy Transfer LP:企業の戦略・SWOT・財務分析
    Energy Transfer LP - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ramsay Health Care Limited:企業の戦略・SWOT・財務情報
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • OncoSec Medical Inc (ONCS):医療機器:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Concert Pharmaceuticals Inc (CNCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Concert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology company which discovers and develops small molecule drugs. The company develops its products using its deuterated chemical entity (DCE) platform to develop novel therapeutics for autoimmune and inflammato …
  • EpiVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EpiVax Inc (EpiVax) develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which ac …
  • Genedata AG-製薬・医療分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Factor Therapeutics Ltd (FTT)-製薬・医療分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆